Nab-paclitaxel + Carboplatin: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Nab-paclitaxel + Carboplatin

• A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
  NCT07365319 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 24 locations
• Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer
  NCT04159142 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer
  NCT04138719 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT
  NCT04137653 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: Female · 1 location

Common questions

How many recruiting trials involve Nab-paclitaxel + Carboplatin?

4 recruiting trials across 6 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.